Signatera MRD Test Gets Breakthrough Device Designations
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Molecular Diagnostics |
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Pancreatic |
Researchers have discovered how cellular stress and inflammation drive pancreatic cancer progression via the STAT3-ITGB3 pathway.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Cancer |
Researchers have shown that molecules in exhaled breath can help detect blood cancer, paving the way for a lnon-invasive breathalyzer test.
Read MorePosted by Chris Wolski | Jul 21, 2025 | Cancer |
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read MorePosted by Chris Wolski | Jul 11, 2025 | Lab Automation |
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
Read More